Combretastatin A-4 analogs: Past, present, and future directions
Last updated: 29 Dec 2024
10.21608/odr.2022.156180.1008
Tubulin polymerization inhibitors, Combretastatin A-4, Anticancer agents, Heterocyclic compounds
Muhamad
Mustafa
IBMM, Univ. Montpellier, CNRS, ENSCM, Montpellier, France
muhamad-mustafa.hussein@umontpellier.fr
Montpellier
0000-0002-1384-7556
Yaser
A. Mostafa
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt
yaser_22a@hotmail.com
Atef
E. Abd Elbaky
Biochemistry Department, Faculty of Pharmacy, Port Said University
atef.ebrahim@pharm.psu.edu.eg
Mahmoud
Mohamed
Pharmacognosy Department, College of Clinical Pharmacy, Albaha University, Saudi Arabia
m_hamed2000@yahoo.com
Dalia
Abdelhamid
Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt
das184@yahoo.com
ElShimaa
M. N. Abdelhafez
Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt
shimaanaguib_80@yahoo.com
Omar
Aly
M.
Department of Medicinal Chemistry, Faculty of Pharmacy, Port Said University
omarsokkar@pharm.psu.edu.eg
Port Said
0000-0001-9299-920X
1
1
36747
2022-09-01
2022-08-14
2022-09-01
55
64
2812-6351
2812-636X
https://odr.journals.ekb.eg/article_257291.html
https://odr.journals.ekb.eg/service?article_code=257291
6
Review Articles
2,486
Journal
Octahedron Drug Research
https://odr.journals.ekb.eg/
Combretastatin A-4 analogs: Past, present, and future directions
Details
Type
Article
Created At
23 Jan 2023